We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$96.1B
1-Year Est. Return
40.06%
This Fund
S&P 500
This Quarter
Est. Return
+1.66%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$40.3B
AUM Growth
-$672M
(-1.6%)
Cap. Flow
-$694M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
14.49%
Holding
2,585
New
23
Increased
499
Reduced
843
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$297M |
| 2 |
Tapestry
TPR
|
+$225M |
| 3 |
SLB Ltd
SLB
|
+$167M |
| 4 |
Qualcomm
QCOM
|
+$165M |
| 5 |
Applied Materials
AMAT
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$197M |
| 2 |
Nike
NKE
|
+$187M |
| 3 |
JAH
JARDEN CORPORATION
JAH
|
+$185M |
| 4 |
Intel
INTC
|
+$177M |
| 5 |
Cognizant
CTSH
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.25% |
| 2 | Healthcare | 14.2% |
| 3 | Consumer Discretionary | 12.55% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
DaVita
DVA
$11.5B
| $7.66M | 0.02% |
104,449
-2,679
| -3% | -$181K |
|
627
Prothena Corp
PRTA
$469M
| $7.66M | 0.02% |
186,223
+23,850
| +15% | +$933K |
|
|
FITB
628
Fifth Third Bancorp
FITB
$52.3B
| $7.65M | 0.02% |
458,180
-13,231
| -3% | -$218K |
|
629
ResMed
RMD
$32.4B
| $7.63M | 0.02% |
131,909
+53,437
| +68% | +$3.02M |
|
630
SITE Centers
SITC
$157M
| $7.57M | 0.02% |
330,329
-104,595
| -24% | -$2.25M |
|
631
Agilent Technologies
A
$42.3B
| $7.56M | 0.02% |
189,803
-5,244
| -3% | -$200K |
|
632
JetBlue
JBLU
$2.18B
| $7.54M | 0.02% |
356,846
-7,538
| -2% | -$159K |
|
633
Vertex Pharmaceuticals
VRTX
$135B
| $7.53M | 0.02% |
94,750
-1,371
| -1% | -$124K |
|
634
Newell Brands
NWL
$2.64B
| $7.51M | 0.02% |
169,680
-4,079
| -2% | -$160K |
|
635
Waters Corp
WAT
$40.7B
| $7.49M | 0.02% |
56,762
-599,217
| -91% | -$74.7M |
|
|
DEA
636
Easterly Government Properties
DEA
$1.14B
| $7.48M | 0.02% |
161,650
+31,740
| +24% | +$1.38M |
|
637
Federal Realty Investment Trust
FRT
$10.2B
| $7.44M | 0.02% |
47,689
+8,934
| +23% | +$1.34M |
|
638
Brown-Forman Class B
BF.B
$12.8B
| $7.43M | 0.02% |
235,909
-6,941
| -3% | -$215K |
|
|
CA
639
DELISTED
CA, Inc.
CA
| $7.42M | 0.02% |
240,962
+61,895
| +35% | +$1.78M |
|
|
SRCL
640
DELISTED
Stericycle Inc
SRCL
| $7.41M | 0.02% |
58,727
-1,518
| -3% | -$177K |
|
641
Viatris
VTRS
$18.7B
| $7.37M | 0.02% |
159,069
-2,900
| -2% | -$140K |
|
|
LLTC
642
DELISTED
Linear Technology Corp
LLTC
| $7.37M | 0.02% |
165,383
-4,223
| -2% | -$179K |
|
|
XLNX
643
DELISTED
Xilinx Inc
XLNX
| $7.34M | 0.02% |
154,691
-4,022
| -3% | -$189K |
|
|
PTLA
644
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.27M | 0.02% |
356,476
+74,350
| +26% | +$2.36M |
|
|
CTRA
645
DELISTED
Coterra Energy
CTRA
| $7.25M | 0.02% |
319,215
+26,225
| +9% | +$526K |
|
646
Labcorp
LH
$26.1B
| $7.25M | 0.02% |
72,011
-1,508
| -2% | -$145K |
|
647
Campbell Soup
CPB
$6.73B
| $7.23M | 0.02% |
113,415
-2,712
| -2% | -$159K |
|
|
WRK
648
DELISTED
WestRock Company
WRK
| $7.22M | 0.02% |
205,221
-11,503
| -5% | -$375K |
|
649
Kohl's
KSS
$2.11B
| $7.2M | 0.02% |
154,440
-37,002
| -19% | -$1.74M |
|
650
Ball Corp
BALL
$16.7B
| $7.2M | 0.02% |
201,870
+7,460
| +4% | +$254K |
|
Similar funds
VOYA Investment Management's Q1 2016 Portfolio in Review
As of Q1 2016, VOYA Investment Management held 2,585 positions worth $40.3B, down 1.6% from $41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2016: portfolio turnover was 3.7%. VOYA Investment Management opened 23 new positions and exited 72, leaving the 2,585-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- VOYA Investment Management's largest Q1 2016 buy was AstraZeneca: 495,025 shares worth $27.9M.
- VOYA Investment Management added most to AbbVie in Q1 2016, an estimated $297M increase.
- VOYA Investment Management's biggest Q1 2016 reduction was Pfizer, cutting an estimated $197M.
- VOYA Investment Management fully exited Blackstone in Q1 2016, selling an estimated $61.8M.
- VOYA Investment Management's ten largest holdings make up 14% of its $40.3B portfolio in Q1 2016.
- VOYA Investment Management opened 23 new positions and closed 72 in Q1 2016.
- VOYA Investment Management's portfolio value fell 1.6% quarter-over-quarter to $40.3B.
Based on VOYA Investment Management's 13F filing for Q1 2016, filed 16 May 2016.